Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
136
Top-10 weight
24.04%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
80
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1023.4
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 767 | $705.46K | 3.67% |
| 2 | JOHNSON&JOHNSON | — | 2,562 | $626.26K | 3.25% |
| 3 | ABBVIE INC | — | 2,273 | $494.35K | 2.57% |
| 4 | MERCK & CO | — | 3,751 | $451.21K | 2.34% |
| 5 | UNITEDHEALTH GRP | — | 1,485 | $401.83K | 2.09% |
| 6 | THERMO FISHER SCIENTIFIC INC | — | 732 | $359.80K | 1.87% |
| 7 | AMGEN INC | — | 995 | $350.09K | 1.82% |
| 8 | ABBOTT LABS | — | 3,259 | $334.60K | 1.74% |
| 9 | PFIZER INC | — | 11,904 | $334.26K | 1.74% |
| 10 | GILEAD SCIENCES INC | — | 2,379 | $331.56K | 1.72% |
| 11 | INTUITIVE SURGICAL INC | — | 704 | $324.54K | 1.69% |
| 12 | DANAHER CORP | — | 1,546 | $293.12K | 1.52% |
| 13 | BRISTOL-MYERS SQUIBB CO | — | 4,808 | $291.61K | 1.52% |
| 14 | STRYKER CORP | — | 838 | $275.36K | 1.43% |
| 15 | VERTEX PHARMACEUTICALS INC | — | 599 | $267.48K | 1.39% |
| 16 | MCKESSON CORP | — | 289 | $250.09K | 1.30% |
| 17 | CENCORA INC | — | 791 | $248.48K | 1.29% |
| 18 | REGENERON PHARMACEUTICALS INC | — | 309 | $238.75K | 1.24% |
| 19 | BOSTON SCIENTIFIC CORP | — | 3,803 | $238.64K | 1.24% |
| 20 | CVS HEALTH CORP | — | 3,288 | $236.14K | 1.23% |
| 21 | THE CIGNA GROUP | — | 798 | $212.87K | 1.11% |
| 22 | ELEVANCE HEALTH INC | — | 712 | $208.44K | 1.08% |
| 23 | HCA HEALTHCARE INC | — | 436 | $206.33K | 1.07% |
| 24 | ZOETIS INC CL A | — | 1,509 | $178.38K | 0.93% |
| 25 | CARDINAL HEALTH INC | — | 833 | $176.02K | 0.91% |
| 26 | ALNYLAM PHARMACEUTICALS INC | — | 526 | $174.04K | 0.90% |
| 27 | IDEXX LABS INC | — | 309 | $173.62K | 0.90% |
| 28 | MEDTRONIC PLC | — | 1,996 | $172.95K | 0.90% |
| 29 | BECTON DICKINSON and CO | — | 1,095 | $172.17K | 0.89% |
| 30 | EDWARDS LIFESCIENCES CORP | — | 2,128 | $170.41K | 0.89% |
| 31 | INSMED INC | — | 1,004 | $164.17K | 0.85% |
| 32 | OPTION | NVO US | 4,453 | $163.65K | 0.85% |
| 33 | Icon Public Limited Company | ICLR | 1,465 | $162.12K | 0.84% |
| 34 | ASTRAZENECA PLC | — | 805 | $158.76K | 0.82% |
| 35 | ARGENX SE SPONSORED ADR | — | 217 | $158.46K | 0.82% |
| 36 | ALKERMES PLC | — | 4,404 | $155.73K | 0.81% |
| 37 | BEONE MEDICINES LTD ADR | — | 515 | $152.94K | 0.79% |
| 38 | AGILENT TECHNOLOGIES INC | — | 1,311 | $149.43K | 0.78% |
| 39 | JAZZ PHARMA PLC | — | 785 | $148.40K | 0.77% |
| 40 | GE HEALTHCARE TECHNOLOGIES INC WI | — | 2,066 | $147.06K | 0.76% |
| 41 | RESMED INC | — | 652 | $146.36K | 0.76% |
| 42 | WATERS CORP | — | 489 | $145.62K | 0.76% |
| 43 | IQVIA HOLDINGS INC | — | 842 | $143.59K | 0.75% |
| 44 | TEVA PHARMACEUTICAL IND ADR | — | 4,690 | $141.26K | 0.73% |
| 45 | NATERA INC | — | 699 | $139.79K | 0.73% |
| 46 | UNITED THERAPEUTICS CORP DEL | — | 234 | $138.76K | 0.72% |
| 47 | METTLER-TOLEDO INTL INC | — | 110 | $138.73K | 0.72% |
| 48 | GSK plc SPONSORED ADR | GSK US | 2,483 | $137.04K | 0.71% |
| 49 | BIOGEN INC | — | 734 | $134.56K | 0.70% |
| 50 | ROYALTY PHARMA PLC | — | 2,759 | $132.35K | 0.69% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.